Cargando…
ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression
According to our prior findings, ARID1A expression is decreased in colon cancer, which has a poor prognosis. In this study, we investigated the ARID1A‐VIM/CDH1 signalling axis's role in colon cancer proliferation and migration. The differentially expressed genes in cells that might be controlle...
Autores principales: | Baldi, Salem, Zhang, Qianshi, Zhang, Zhenyu, Safi, Mohammed, Khamgan, Hassan, Wu, Han, Zhang, Mengyan, Qian, Yuanyuan, Gao, Yina, Shopit, Abdullah, Al‐Danakh, Abdullah, Alradhi, Mohammed, Al‐Nusaif, Murad, Zuo, Yunfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753436/ https://www.ncbi.nlm.nih.gov/pubmed/36420658 http://dx.doi.org/10.1111/jcmm.17590 |
Ejemplares similares
-
Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022) -
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2021) -
Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
por: Alradhi, Mohammed, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study
por: Al-Danakh, Abdullah, et al.
Publicado: (2022) -
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation
por: Alradhi, Mohammed, et al.
Publicado: (2022)